Evolution of the Average Target: Imexpharm Corporation

Evolution of the Average Target - Imexpharm Corporation

Evolution of the Target Price: Imexpharm Corporation

Evolution of the Target Price - Imexpharm Corporation

Changes in Analyst Recommendations: Imexpharm Corporation

1bc8faec4c9cee2677590c5.VmTOrlu9IanGy0ns4S2JFRdpXd_McEFMfKN55-t4GCQ.FS2Z5SuPR_73_x3VpH7mV0UzC-yVL3J0SpcesYA1cWUBV4KaLfNZhPeCEA~534948dadf43d75c2fb87ad8554f7fe3

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - +64.71%
+8.8%
+4.5%
+11.41%
-0.35%
+21.62%
+1.75%
+23.51%
-0.69%
+5.64%
Average +14.09%
Weighted average by Cap. +8.40%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
34,000.00VND
Average target price
56,000.00VND
Spread / Average Target
+64.71%
High Price Target
56,000.00VND
Spread / Highest target
+64.71%
Low Price Target
56,000.00VND
Spread / Lowest Target
+64.71%

Analyst Consensus Detail

Analyst consensus - Imexpharm Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Imexpharm Corporation
  1. Stock Market
  2. Stocks
  3. IMP Stock
  4. Consensus Imexpharm Corporation